Details for Patent: 9,241,915
✉ Email this page to a colleague
Which drugs does patent 9,241,915 protect, and when does it expire?
Patent 9,241,915 protects OSPHENA and is included in one NDA.
This patent has twenty-nine patent family members in twenty-one countries.
Summary for Patent: 9,241,915
| Title: | Method for enhancing the bioavailability of ospemifene |
| Abstract: | This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food. |
| Inventor(s): | Anttila; Markku (Turku, FI) |
| Assignee: | QuatRx Pharmaceuticals (Ann Arbor, MI) |
| Application Number: | 14/310,822 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
More… ↓ |
Drugs Protected by US Patent 9,241,915
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF VAGINAL SYMPTOMS OF UROGENITAL ATROPHY BY ORALLY ADMINISTERING OSPEMIFENE WITH FOOD TO ENHANCE BIOAVAILABILITY OF OSPEMIFENE | ⤷ Subscribe | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE | ⤷ Subscribe | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,241,915
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1713458 | ⤷ Subscribe | CA 2015 00031 | Denmark | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | C300742 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | 92736 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | PA2015023 | Lithuania | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | 15C0041 | France | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | CR 2015 00031 | Denmark | ⤷ Subscribe |
| European Patent Office | 1713458 | ⤷ Subscribe | C20150029 00165 | Estonia | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
